Clinical Trials
3 trialsNCT04767009 2025-04-30
SBRT for Oligo-residual NSCLC After Treatment With PD-1/PD-L1 Immune Checkpoint Inhibitors
Fudan University
Phase 2 Unknown
NCT06030622 2024-04-19
C3
State University of New York - Downstate Medical Center
Phase 1/2 Unknown
NCT03347045 2017-11-20
TPC-RCT
Alberta Health Services, Calgary
Phase NA Unknown